GSK settles Zantac cases after claiming popular heartburn drug causes cancer
Top line Pharma heavyweight GSK said on Wednesday it had settled four lawsuits in the US that claimed its popular heartburn drug Zantac caused cancer, blocking a trial that was due to begin in California next month as it and other pharmaceutical companies work to manage the looming regulatory threats posed by the discontinued drug. … Read more